The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model
Shares:
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
It’s been kind of a wild week, and you’re all probably due for a slightly less verbose Curve today. (It’s not a shorter newsletter, though … but that’s a problem
I was excited yesterday by the even-handed coverage of the move, by Harrow, to increase the price of an eye treatment from $161 to $944 per unit. But 46Brooklyn’s Antonio